Evaluation of [18F]PSMA-1007 uptake variability in patients with prostate cancer
{{output}}
Background: The biodistribution of PSMA-ligands is of interest in radionuclide therapy planning. We investigated the variability of [18F]PSMA-1007 uptake in organs at risk and in relation to tumour burden in prostate cancer patie... ...
